Expressions of SLIT2 and ROBO1 are downregulated in ductal carcinoma in situ and invasive breast cancer tissues, and such downregulation is associated with poor prognosis and brain metastasis of breast cancer [32]. Here, SLIT2 is linked to invasive breast carcinoma.